Navigator‐3, a modulator of cell migration, may act as a suppressor of breast cancer progression by Hadas Cohen‐Dvashi, Nir Ben‐Chetrit, Roslin Russell, Silvia Carvalho, Mattia Lauriola, Sophia Nisani, Maicol Mancini, Nishanth Nataraj, Merav Kedmi, Lee Roth, Wolfgang Köstler, Amit Zeisel, Assif Yitzhaky, Jacques Zylberg, Gabi Tarcic, Raya Eilam, Yoav Wigelman, Rainer Will, Sara Lavi, Ziv Porat, Stefan Wiemann, Sara Ricardo, Fernando Schmitt, Carlos Caldas, Yosef Yarden

Get full text

A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers by Alberto D. Guerra, Smita Matkar, Christina Acholla, Colleen Casey, Grant Li, Martina Mazzeschi, Khushbu Patel, Kateryna Krytska, Chuan Chen, Skye Balyasny, Joshua Kalna, Paul Kamitsuka, Mark Gerelus, Grace Polkosnik, David Groff, Apratim Mukherje, Cynthia Adams, Gabriela Witek, Amber K. Hamilton, Daniel Martinez, Jennifer Pogoriler, Timothy T. Spear, Yimei Li, Piotr Jung, Diego Alvarado, Mattia Lauriola, John M. Maris, Adam J. Wolpaw, Kristopher R. Bosse, Dimiter Dimitrov, Mustafa Mir, Dontcho V. Jelev, Yael P. Mossé

Get full text